Skip to main content
S 4253 116th Congress Senate Health Drug safety, medical device, and laboratory regulation Government information and archives Intellectual property Prescription drugs

Second Look at Drug Patents Act of 2020

Introduced: July 21, 2020 Introduced by: Murray, Patty Democratic · Washington See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 116th Congress ended
It never became law before the 116th Congress (2019–2020) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 21, 2020
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Jul 21, 2020
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Second Look at Drug Patents Act of 2020

This bill imposes additional patent reporting requirements on the manufacturers of certain drugs approved by the Federal Drug Administration.

What's happening now July 21, 2020

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Related & companion bills 1
  • S 1617 Related bill Second Look at Drug Patents Act of 2019
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 1
All 1 Republican 1
R
Cornyn, John
Texas · Jul 21, 2020
Cite this page click to expand
APA
U.S. Congress. (2026). S. 4253: Second Look at Drug Patents Act of 2020. 116th Congress. Open America. https://openamerica.io/bill/116-S-4253/
MLA
"S. 4253: Second Look at Drug Patents Act of 2020." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-S-4253/.
Bluebook (legal)
S. 4253, 116th Cong. (2026), https://openamerica.io/bill/116-S-4253/.
Markdown link
[S. 4253: Second Look at Drug Patents Act of 2020](https://openamerica.io/bill/116-S-4253/)
Report a problem